Zomedica Corp. (ZOM)
NYSEAMERICAN: ZOM · Real-Time Price · USD
0.128
+0.003 (2.15%)
Jan 22, 2025, 2:44 PM EST - Market open
Zomedica Employees
Zomedica had 144 employees as of December 31, 2023. The number of employees increased by 59 or 69.41% compared to the previous year.
Employees
144
Change (1Y)
59
Growth (1Y)
69.41%
Revenue / Employee
$185,604
Profits / Employee
-$431,903
Market Cap
125.43M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ZOM News
- 15 days ago - Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market - Accesswire
- 4 weeks ago - Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone - Accesswire
- 4 weeks ago - Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer - Accesswire
- 2 months ago - Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024 - Accesswire
- 2 months ago - Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform - Accesswire
- 2 months ago - Noble Capital Markets Initiates Equity Research Coverage on Zomedica - Accesswire
- 2 months ago - Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024 - Accesswire
- 2 months ago - Zomedica Corp. (ZOM) Q3 2024 Earnings Call Transcript - Seeking Alpha